Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 82
  • Journal CiteScore: 35.06
  • Journal Impact Factor: 24.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Abstract

Survival rate of patients with Pancreatoblastoma (PBL)

Justin Gillman*

Pancreatoblastoma (PBL) is a very rare childhood tumour that develops from pancreatic epithelial exocrine cells. It is the most common malignant pancreatic tumour in children under the age of five, with a mean age of diagnosis of five years. It grows slowly, and its appearance is varied and frequently non-specific. If the tumour is resectable, the prognosis for paediatric cases is usually good, but recurrences do occur. PBL has an aggressive course and a poor prognosis if it is unresectable and has metastasis. Adult cases typically have a shorter survival time, with a median survival time of 15 months. Awareness of this rare pancreatic tumour is critical for early detection and management.

Published Date: 2022-08-25; Received Date: 2022-07-27